REFERENCES
- Stagno S. Cytomegalovirus. In Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant, 5th edn. Philadelphia: WB Saunders, 2001:389–424
- Fowler KB, Stagno S, Pass RF, et at. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663–7
- Nigro G, Mazzocco M, Anceschi MM, et at. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol 1999;94:909–14
- Boppana SB, Fowler KB, Britt WJ, et at. Symptomatic congenital cytomegalovirus infection in infants born to mothers with pre-existing immunity to cytomegalovirus. Pediatrics 1999;104:55–60
- Nigro G, Krzysztofiak A, Bartmann U, et at. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997;142:573–80
- Tajiri H, Kozaiwa K, Tanaka-Taya K, et at. Cytomegalovirus hepatitis confirmed by in situ hybridization in 3 immunocom-petent infants. Scand J Infect Dis 2001;33: 790–3
- Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990;39:597–638
- Nigro G, Bartmann U, Mattia S, et at. Acute hepatitis in childhood: virological, immunological and clinical aspects. Biomed Pharmacother 1992;46:155–60
- Nigro G, La Torre R, Mazzocco M, et at. Multi-system cytomegalovirus fetopathy by recurrent infection in a pregnant woman with hepatitis B. Prenat Diagn 1999;19:1070–2
- Zaia JA. Pathogenesis of CMV-associated disease in 1990. Transplant 1991;23 (Suppl 3):1–4
- Chrisp P, Clissold SP. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991;41:104–29
- Eckle T, Prix L, Jahn G, et at. Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood 2000;96:3286–9
- Ohta H, Matsuda Y, Tokimara S, et at. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA. Bone Marrow Trans-plant 2001;27:1141–5